GT BIOPHARMA, INC. Amortization of Debt Discount (Premium)
GT BIOPHARMA, INC. (GTBP) reported Amortization of Debt Discount (Premium) of $0 for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2022-03-28
- GT BIOPHARMA, INC. amortization of debt discount (premium) for the quarter ending 2021-09-30 was $0.00.
- GT BIOPHARMA, INC. amortization of debt discount (premium) for the quarter ending 2020-12-31 was $317.00K, a 487.04% increase year-over-year.
- GT BIOPHARMA, INC. amortization of debt discount (premium) for the quarter ending 2020-09-30 was -$1.00K, a 100.83% decline year-over-year.
- GT BIOPHARMA, INC. amortization of debt discount (premium) for the quarter ending 2020-06-30 was $1.00K, a 99.40% decline year-over-year.
- GT BIOPHARMA, INC. amortization of debt discount (premium) for fiscal 2020 was $317.00K, a 37.23% decline from fiscal 2019.
- GT BIOPHARMA, INC. amortization of debt discount (premium) for fiscal 2019 was $505.00K, a 94.17% decline from fiscal 2018.
- GT BIOPHARMA, INC. amortization of debt discount (premium) for fiscal 2018 was $8.66M, a 76.29% increase from fiscal 2017.
- GT BIOPHARMA, INC. amortization of debt discount (premium) for fiscal 2017 was $4.91M, a 69.62% increase from fiscal 2016.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | $0.00 10-Q/A · filed 2021-12-29 | |||
| 2020-12-31 | $317.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $316.00K derived: sum of 2 quarters · filed 2022-03-28 | $317.00K derived: sum of 3 quarters · filed 2022-03-28 | $317.00K 10-K · filed 2022-03-28 |
| 2020-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2021-12-29 | $0.00 10-Q · filed 2020-11-13 | $54.00K derived: sum of 4 quarters · filed 2021-12-29 |
| 2020-06-30 | $1.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2021-12-29 | $1.00K 10-Q/A · filed 2021-12-29 | $55.00K derived: sum of 3 quarters · filed 2021-12-29 | $175.00K derived: sum of 4 quarters · filed 2021-12-29 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-15 | $54.00K derived: sum of 2 quarters · filed 2021-04-16 | $174.00K derived: sum of 3 quarters · filed 2021-04-16 | $342.00K derived: sum of 4 quarters · filed 2021-04-16 |
| 2019-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-16 | $174.00K derived: sum of 2 quarters · filed 2021-04-16 | $342.00K derived: sum of 3 quarters · filed 2021-04-16 | $505.00K 10-K · filed 2021-04-16 |
| 2019-09-30 | $120.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-13 | $288.00K derived: sum of 2 quarters · filed 2020-11-13 | $451.00K 10-Q · filed 2020-11-13 | $1.30M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $168.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-18 | $331.00K 10-Q/A · filed 2020-08-18 | $1.18M derived: sum of 3 quarters · filed 2020-08-18 | $2.14M derived: sum of 4 quarters · filed 2020-08-18 |
| 2019-03-31 | $163.00K 10-Q · filed 2020-05-15 | $1.01M derived: sum of 2 quarters · filed 2020-05-15 | $1.97M derived: sum of 3 quarters · filed 2020-05-15 | $6.16M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $847.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $1.81M derived: sum of 2 quarters · filed 2020-03-27 | $6.00M derived: sum of 3 quarters · filed 2020-03-27 | $8.66M 10-K · filed 2020-03-27 |
| 2018-09-30 | $961.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $5.15M derived: sum of 2 quarters · filed 2019-11-14 | $7.82M 10-Q · filed 2019-11-14 | $7.94M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $4.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $6.86M 10-Q · filed 2019-08-14 | $6.98M derived: sum of 3 quarters · filed 2019-08-14 | $10.39M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $2.67M 10-Q · filed 2019-05-15 | $2.79M derived: sum of 2 quarters · filed 2019-05-15 | $6.20M derived: sum of 3 quarters · filed 2019-05-15 | $6.76M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $3.54M derived: sum of 2 quarters · filed 2019-03-29 | $4.10M derived: sum of 3 quarters · filed 2019-03-29 | $4.91M 10-K · filed 2019-03-29 |
| 2017-09-30 | $3.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $3.98M derived: sum of 2 quarters · filed 2018-11-14 | $4.79M 10-Q · filed 2018-11-14 | $6.06M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $562.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $1.38M 10-Q · filed 2018-08-14 | $2.65M derived: sum of 3 quarters · filed 2018-08-14 | $3.30M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $814.00K 10-Q · filed 2018-05-15 | $2.09M derived: sum of 2 quarters · filed 2018-05-15 | $2.74M derived: sum of 3 quarters · filed 2018-05-15 | $2.90M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $1.27M derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | $1.93M derived: sum of 2 quarters · filed 2018-03-01 | $2.09M derived: sum of 3 quarters · filed 2018-03-01 | $2.90M 10-K · filed 2018-03-01 |
| 2016-09-30 | $653.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-02-28 | $818.00K derived: sum of 2 quarters · filed 2018-02-28 | $1.63M 10-Q/A · filed 2018-02-28 | $2.39M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $165.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-02-28 | $972.00K 10-Q/A · filed 2018-02-28 | $1.73M derived: sum of 3 quarters · filed 2018-02-28 | $2.42M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $807.00K 10-Q/A · filed 2018-02-28 | $1.57M derived: sum of 2 quarters · filed 2018-02-28 | $2.26M derived: sum of 3 quarters · filed 2018-02-28 | $2.90M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $762.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-02-28 | $1.45M derived: sum of 2 quarters · filed 2018-02-28 | $2.10M derived: sum of 3 quarters · filed 2018-02-28 | $2.49M 10-K/A · filed 2018-02-28 |
| 2015-09-30 | $689.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-02-28 | $1.33M derived: sum of 2 quarters · filed 2018-02-28 | $1.73M 10-Q/A · filed 2018-02-28 | $2.86M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-06-30 | $644.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-02-28 | $1.04M 10-Q/A · filed 2018-02-28 | $2.17M derived: sum of 3 quarters · filed 2018-02-28 | $3.61M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-03-31 | $399.00K 10-Q/A · filed 2018-02-28 | $1.52M derived: sum of 2 quarters · filed 2018-02-28 | $2.97M derived: sum of 3 quarters · filed 2018-02-28 | $3.04M derived: sum of 4 quarters · filed 2018-02-28 |
| 2014-12-31 | $1.12M derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-02-28 | $2.57M derived: sum of 2 quarters · filed 2018-02-28 | $2.64M derived: sum of 3 quarters · filed 2018-02-28 | $2.76M 10-K/A · filed 2018-02-28 |
| 2014-09-30 | $1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $1.51M derived: sum of 2 quarters · filed 2015-11-13 | $1.64M 10-Q · filed 2015-11-13 | $1.69M derived: sum of 4 quarters · filed 2015-11-13 |
| 2014-06-30 | $68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $188.00K 10-Q · filed 2015-08-14 | $238.00K derived: sum of 3 quarters · filed 2015-08-14 | $340.00K derived: sum of 4 quarters · filed 2015-08-14 |
| 2014-03-31 | $120.00K 10-Q · filed 2015-05-14 | $170.00K derived: sum of 2 quarters · filed 2015-05-14 | $272.00K derived: sum of 3 quarters · filed 2015-05-14 | $515.00K derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $152.00K derived: sum of 2 quarters · filed 2015-03-31 | $395.00K derived: sum of 3 quarters · filed 2015-03-31 | $689.00K 10-K · filed 2015-03-31 |
| 2013-09-30 | $102.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-01-08 | $345.00K derived: sum of 2 quarters · filed 2015-01-08 | $639.00K 10-Q · filed 2015-01-08 | $639.00K derived: sum of 4 quarters · filed 2015-01-08 |
| 2013-06-30 | $243.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-08 | $537.00K 10-Q · filed 2015-01-08 | $537.00K derived: sum of 3 quarters · filed 2015-01-08 | $537.00K derived: sum of 4 quarters · filed 2015-01-08 |
| 2013-03-31 | $294.00K 10-Q · filed 2015-01-08 | $294.00K derived: sum of 2 quarters · filed 2015-01-08 | $294.00K derived: sum of 3 quarters · filed 2015-01-08 | $305.00K derived: sum of 4 quarters · filed 2015-01-08 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-08 | $0.00 derived: sum of 2 quarters · filed 2015-01-08 | $11.00K derived: sum of 3 quarters · filed 2015-01-08 | $40.00K 10-K · filed 2015-01-08 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-12-17 | $11.00K derived: sum of 2 quarters · filed 2014-12-17 | $40.00K 10-Q · filed 2014-12-17 | $18.00K derived: sum of 4 quarters · filed 2014-12-17 |
| 2012-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-12 | $40.00K 10-Q · filed 2014-12-12 | $18.00K derived: sum of 3 quarters · filed 2014-12-12 | $72.00K derived: sum of 4 quarters · filed 2014-12-12 |
| 2012-03-31 | $29.00K 10-Q · filed 2014-12-10 | $7.00K derived: sum of 2 quarters · filed 2014-12-10 | $61.00K derived: sum of 3 quarters · filed 2014-12-10 | $230.00K derived: sum of 4 quarters · filed 2014-12-10 |
| 2011-12-31 | -$22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-18 | $32.00K derived: sum of 2 quarters · filed 2014-11-18 | $201.00K derived: sum of 3 quarters · filed 2014-11-18 | $284.00K 10-K · filed 2014-11-18 |
| 2011-09-30 | $54.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-21 | $223.00K derived: sum of 2 quarters · filed 2012-11-21 | $306.00K 10-Q · filed 2012-11-21 | $378.00K derived: sum of 4 quarters · filed 2012-11-21 |
| 2011-06-30 | $169.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-13 | $252.00K 10-Q/A · filed 2012-09-13 | $324.00K derived: sum of 3 quarters · filed 2012-09-13 | $475.00K derived: sum of 4 quarters · filed 2012-09-13 |
| 2011-03-31 | $83.00K 10-Q · filed 2012-05-21 | $155.00K derived: sum of 2 quarters · filed 2012-05-21 | $306.00K derived: sum of 3 quarters · filed 2012-05-21 | |
| 2010-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $223.00K derived: sum of 2 quarters · filed 2012-04-16 | $441.00K 10-K · filed 2012-04-16 | |
| 2010-09-30 | $151.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $369.00K 10-Q · filed 2011-11-21 | ||
| 2010-06-30 | $218.00K 10-Q/A · filed 2011-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |